🇺🇸 FDA
Patent

US 8242076

Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair

granted A61PA61P17/00A61P43/00

Quick answer

US patent 8242076 (Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair) held by The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center
Grant date
Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P17/00, A61P43/00